HIGHLIGHTS
- What: The authors propose that Frontiers in Cell and Developmental Biology A phase II trial was designed to determine the chemopreventive properties of capsaicin in PCa patients enrolled in the active surveillance program or patients scheduled to undergo radical prostatectomy (NCT02037464).
- Who: Antal Nógrádi et al. from the University of Szeged, Hungary University of Pennsylvania, United States have published the article: Prostate cancer stem cells and their targeted therapies, in the Journal: (JOURNAL)
- How: In 2021 an ongoing phase II clinical trial of avelumab was designed to evaluate its effects against . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.